CI
BMY icon

Cowen Inc’s Bristol-Myers Squibb BMY Stock Holding History

Cowen Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-536,800
Closed -$644K – 465
2019
Q1 		$644K Buy
+536,800
New +$26.7M 0.07% 141
2018
Q2 		– Sell
-9,400
Closed -$595K – 499
2018
Q1 		$595K Buy
+9,400
New +$605K ﹤0.01% 122
2017
Q2 		– Sell
-500
Closed -$2.72M – 312
2017
Q1 		$2.72M Buy
+500
New +$27.4K 0.13% 78

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cowen Inc's BMY Position: Q2 2019 in Review

Cowen Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 16,200 shares — an estimated $755K sold.

Cowen Inc first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $3.7M in Q2 2013. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Cowen Inc reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
  • Cowen Inc sold 16,200 Bristol-Myers Squibb shares in Q2 2019, an estimated $755K.
  • Cowen Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
  • Cowen Inc's Bristol-Myers Squibb position peaked at $3.7M in Q2 2013.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.